EMAS Virtual School

Menopause and metabolic disease

in collaboration with the Hellenic Society of Climacterium and Menopause

Learning objectives

Participants should acquire the skills to assess and manage women during the menopause transition in the context of metabolic disease.

The focus will be to understand the metabolic changes induced by menopause and the long-term health consequences of metabolic disease, to assess and treat women with menopausal symptoms and co-existing cardiometabolic risk factors and finally to individualize treatment of diabetes and heart disease in postmenopausal women.

Session structure

Interactive learning and practice exchange with international experts will be structured according to the  following format:

• Short presentations by the international experts.
• Interactive debate in three steps:
• Q & A between the expert speakers and a discussion panel.
• Open dialogue with all attendees.
• Assessment with multiple choice questions using an internet platform.

Meeting details

  • The event will be a virtual meeting and will be accessible from this website
  • Live Interaction with the speakers and Q&A
  • Can be viewed Worldwide with no delay
  • Event start always at 2.00 p.m. CET Paris time = 8.00 a.m. EST New York = 8.00 p.m. Singapore time
  • All delegates will receive a certificate of attendance

Short exposures to update the topic

Interactive debate

Q & A between speaker and a discussant panel

Open debate with the attendees

Verification of the learning process

CONFERENCE SCHEDULE

First Day - 11.12.2020 Time CET = Paris time
14:00-14:10 - Opening and Welcome by Prof. Irene Lambrinoudaki and Assist. Prof. Stavroula A. Paschou
14:10-15:10 - Cardiometabolic changes after Menopause

14:10 - 14:25

Prof. Asimina Mitrakou – Obesity and Diabetes after Menopause

14:25 - 14:40

Prof. Efstathios Manios – Hypertension after Menopause

14:40 - 14:55

Prof. John C Stevenson – Dyslipidaemia after Menopause

14.55-15.10

Prof. Kimon Stamatelopoulos – Cardiovascular risk after Menopause

15:10 - 15:30

Prof. Dimitros G. Goulis – Discussion with Mentees

 

15:30 - 15:40 Coffee Break
15:40 - 16.25 - Metabolic disease: a cause of accelerated aging?

15:40 - 15:55

Prof. Theodora Psaltopoulou – Metabolic disease and risk of cancer

15:55-16:10

Prof. Peter Chedraui – Metabolic disease in women with PCOS after Menopause

16:10 - 16:25

Prof. Rebecca Thurston – Novel Menopause – related risk factors for cardiovascular disease in women

16:25 - 17:00

Prof. Margaret Rees – Discussion with mentees and closing of first day

Second Day 12.12.2020 - Time CET = Paris time
14:00 - 15:30 - Menopausal hormone therapy in the context of cardiometabolic disease

14:00 - 14:15

Assist. Prof. Stavroula A. Paschou – MHT in women with obesity / diabetes (including COVID-19)

14:15 - 14:25

Dr. Panagiotis Anagnostis – MHT in women with dyslipidemias

 

14:25 - 14:35

Prof. Angelica Linden-Hirschberg – MHT in women with hypertension

 

14:35 - 14:50

Prof. Stephanie S. Faubion – MHT and cardiovascular disease

 

 

 

14:50 - 15.30

Prof. Irene Lambrinoudaki – Case discussion with Residents

 

15:30 - 15:40 Coffee Break
15:40 - 16:40 Non-hormonal management of metabolic disease after Menopause

15:40 - 15:50

Prof. Antonio Cano – Diet and metabolic health after Menopause

 

 

15:50 - 16:00

Prof. Risto Erkkola – Exercise after Menopause

 

16:00 - 16:15

Prof. Kalliopi Kotsa – Customizing diabetes management after Menopause 

 

16:15 - 16:30

Prof. Angela Maas – Managing heart disease in women after Menopause

16:30 - 16:55

Prof. Melpomeni Peppa – Case discussion with Residents

 

16:55 - 17:00 Conclusions and Closing by Prof. Irene Lambrinoudaki

SPEAKERS

Faculty

  • Panagiotis Anagnostis, Endocrinologist, Research Associate, 1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki, Greece.
  • Antonio Cano, EMAS President, Professor of Obstetrics and Gynecology, University of Valencia, Spain.
  • Peter Chedraui, EMAS Board member, Professor of Obstetrics and Gynecology, University of Guayaquil, Equador.
  • Risto Erkkola, EMAS Board member, Professor Emeritus of Obstetrics and Gynecology, University Central Hospital, Turku, Finland.
  • Stephanie S. Faubion, The North American Menopause Society Medical Director, Professor and Chair, Department of Medicine, Mayo Clinic, Jacksonville, Florida, Penny and Bill George Director, Mayo Clinic Center for Women’s Health, USA.
  • Dimitrios G. Goulis, EMAS President-Elect, Professor of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki, Greece.
  • Kalliopi Kotsa, Assoc. Professor of Endocrinology and Diabetes, 1st Department of Internal Medicine, Aristotle University of Thessaloniki, Greece.
  • Irene Lambrinoudaki, EMAS Scientific Director, Professor of Endocrinology, 2nd Department of Obstetrics and Gynecology, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Angelica Linden-Hirschberg, EMAS Secretary General, Professor of Gynecology and Reproductive Medicine, Karolinska Institute, Stockholm, Sweden.
  • Angela Maas, Professor of Women’s Cardiac Health, Radboud University Medical Center, The Netherlands.
  • Efstathios Manios, Professor of Cardiology, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Asimina Mitrakou, Professor of Internal Medicine, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Stavroula A. Paschou, Assist. Professor of Endocrinology (elected), School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Melpomeni Peppa, Professor of Endocrinology, 3rd Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Theodora Psaltopoulou, Professor of Internal Medicine, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • Margaret Rees, EMAS Executive Director, Reader Emeritus of Reproductive Medicine, University of Oxford, UK.
  • Kimon Stamatelopoulos, Assoc. Professor of Cardiology, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
  • John Stevenson, Professor of Metabolic Medicine, Imperial College, London, UK.
  • Rebecca Thurston, The North American Menopause Society President, Professor of Psychiatry, Clinical and Translational Science, University of Pittsburgh, PA, USA.